Cargando…
Full versus half dose of antenatal betamethasone to prevent severe neonatal respiratory distress syndrome associated with preterm birth: study protocol for a randomised, multicenter, double blind, placebo-controlled, non-inferiority trial (BETADOSE)
BACKGROUND: Although antenatal betamethasone is recommended worldwide for women at risk of preterm delivery, concerns persist regarding the long-term effects associated with this treatment. Indeed, adverse events, mainly dose-related, have been reported. The current recommended dose of antenatal bet...
Autores principales: | Schmitz, Thomas, Alberti, Corinne, Ursino, Moreno, Baud, Olivier, Aupiais, Camille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373166/ https://www.ncbi.nlm.nih.gov/pubmed/30755164 http://dx.doi.org/10.1186/s12884-019-2206-x |
Ejemplares similares
-
A Bayesian non-inferiority approach using experts’ margin elicitation – application to the monitoring of safety events
por: Aupiais, Camille, et al.
Publicado: (2019) -
Antenatal Betamethasone Every 12 Hours in Imminent Preterm Labour
por: Saldaña-García, Natalia, et al.
Publicado: (2022) -
Retinopathy of Prematurity: Risk Factors and Role of Antenatal Betamethasone in Indian Preterm Newborn Babies
por: Maini, Baljeet, et al.
Publicado: (2014) -
Effects of antenatal betamethasone on preterm human and mouse ductus arteriosus: comparison with baboon data
por: Shelton, Elaine L., et al.
Publicado: (2018) -
Antenatal betamethasone improves postnatal transition in late preterm lambs with persistent pulmonary hypertension of the newborn
por: Konduri, Girija G., et al.
Publicado: (2013)